Table 1
| SWOG/ Support |
STUDY | R E G |
O P E N |
ARM | ACCR. GOAL |
TOTAL REGS. |
REGS. LAST 12 Month |
REGS. LAST 6 Month |
REGS. LAST 3 Month |
REGS. LAST 30 DAYS |
REGS. LAST 7 DAYS |
DATE OF FIRST REG. |
# of ACT. INSTs |
# of CURR IRBs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SWOG | S1613-mCRC, Adv/Met, TP vs CETIRI | 1 | T | 0 Screening | 130 | 148 | 64 | 7 | 0 | 0 | 0 | 11/27/2017 | 301 | 116 |
| 148 | 64 | 7 | 0 | 0 | 0 | |||||||||
| 2 | Y | 1 Trastuzumab + Pertuzumab | 130 | 11 | 7 | 1 | 0 | 0 | 0 | 11/27/2017 | ||||
| 2 Cetuximab + Irinotecan | 12 | 6 | 2 | 0 | 0 | 0 | ||||||||
| 23 | 13 | 3 | 0 | 0 | 0 | |||||||||
| 3 | Y | 3 Crossover: Trastuz + Pertuz | 130 | 8 | 5 | 2 | 0 | 0 | 0 | 11/27/2017 | ||||
| 8 | 5 | 2 | 0 | 0 | 0 | |||||||||
| S1815-Biliary, Met/LocAdv, GC+CPT±Nab-paclitaxel | 1 | Y | 1 Gem+Cisplatin+Nab-paclitaxel | 268 | 78 | 78 | 69 | 44 | 16 | 3 | 02/07/2019 | 253 | 96 | |
| 2 Gemcitabine + Cisplatin | 41 | 41 | 37 | 24 | 8 | 2 | ||||||||
| 119 | 119 | 106 | 68 | 24 | 5 | |||||||||
| Yes | A021502-Colon, Stg III, Chemo +/- Atezol, ATOMIC | 1 | E | Total Registrations | 19 | 13 | 6 | 3 | 2 | 0 | 03/23/2018 | 366 | 170 | |
| 19 | 13 | 6 | 3 | 2 | 0 | |||||||||
| No | A021602-PANC, Adv PNET Blinded Cabozantinib v Placebo | 1 | E | Total Registrations | 3 | 3 | 3 | 2 | 0 | 0 | 06/11/2019 | 202 | 77 | |
| 3 | 3 | 3 | 2 | 0 | 0 | |||||||||
| EA2142-GI NEC, Adv G3, EP vs TMZ + CAP | 1 | E | Total Registrations | 4 | 0 | 0 | 0 | 0 | 0 | 07/14/2016 | 193 | 84 | ||
| 4 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA2161-PANC, Adv Rapalog Resistant PNETs, MLN0128 | 1 | E | Total Registrations | 1 | 0 | 0 | 0 | 0 | 0 | 09/06/2018 | 172 | 61 | ||
| 1 | 0 | 0 | 0 | 0 | 0 | |||||||||
| EA2165-Anal, Stg II-III, Nivolumab after CMT | 1 | E | Total Registrations | 12 | 11 | 6 | 3 | 1 | 0 | 10/09/2018 | 247 | 119 | ||
| 12 | 11 | 6 | 3 | 1 | 0 | |||||||||
| 2 | E | Total Registrations | 9 | 9 | 5 | 2 | 1 | 0 | 10/09/2018 | |||||
| 9 | 9 | 5 | 2 | 1 | 0 | |||||||||
| NRGGI004-Colorectal, Stg IV, dMMR Immuno-Therapy | 1 | E | Total Registrations | 10 | 7 | 3 | 1 | 0 | 0 | 04/18/2018 | 288 | 123 | ||
| 10 | 7 | 3 | 1 | 0 | 0 | |||||||||